Search research articles
Contact Us
Filters
Showing results (111-120 of 186) with videos related to
Page
of 19
Sort By:
The Lancet. Oncology
|
December 8, 2015
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
Shuichi Hironaka, Naotoshi Sugimoto, Kensei Yamaguchi, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
April 20, 2026
Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab response
Yuho Ebata, Eiji Oki, Qingjiang Hu, et al.
Med (New York, N.Y.)
|
June 20, 2024
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC
Hideaki Bando, Daisuke Kotani, Hironaga Satake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2021
Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for <i>RAS</i> Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study
Yoshinori Kagawa, Elena Elez, Jesús García-Foncillas, et al.
JCO Precision Oncology
|
March 30, 2026
Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy
Yuqing Duan, Tadayoshi Hashimoto, Taro Shibuki, et al.
Nature Communications
|
July 13, 2024
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy
Hiroki Osumi, Eiji Shinozaki, Yoshiaki Nakamura, et al.
ESMO Open
|
December 5, 2019
Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with <i>BRAF</i> V600E mutant metastatic colorectal cancer
Toshiki Masuishi, Hiroya Taniguchi, Daisuke Kotani, et al.
JCO Precision Oncology
|
January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial
Mitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
International Journal of Clinical Oncology
|
June 9, 2026
A multicenter survey on BRAF screening for the implementation of perioperative cancer genomic medicine for resectable colorectal oligometastases
Shin Kobayashi, Nobuhisa Matsuhashi, Yusuke Suwa, et al.
Cancer Medicine
|
August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 186) with videos related to
Sort By:
Page
of 19
The Lancet. Oncology
|
December 8, 2015
S-1 plus leucovorin versus S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin in patients with advanced gastric cancer: a randomised, multicentre, open-label, phase 2 trial
Shuichi Hironaka, Naotoshi Sugimoto, Kensei Yamaguchi, et al.
Esophagus : Official Journal of the Japan Esophageal Society
|
April 20, 2026
Gut microbiota diversity in patients with ESCC: associations with esophagectomy, the tumor immune microenvironment, and nivolumab response
Yuho Ebata, Eiji Oki, Qingjiang Hu, et al.
Med (New York, N.Y.)
|
June 20, 2024
QUATTRO-II randomized trial: CAPOXIRI+bevacizumab vs. FOLFOXIRI+bevacizumab as first-line treatment in patients with mCRC
Hideaki Bando, Daisuke Kotani, Hironaga Satake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 19, 2021
Combined Analysis of Concordance between Liquid and Tumor Tissue Biopsies for <i>RAS</i> Mutations in Colorectal Cancer with a Single Metastasis Site: The METABEAM Study
Yoshinori Kagawa, Elena Elez, Jesús García-Foncillas, et al.
JCO Precision Oncology
|
March 30, 2026
Prognostic Biomarkers and Immunotherapeutic Insights of Circulating Tumor DNA Analysis in Advanced Esophageal Squamous Cell Carcinoma From SCRUM-MONSTAR GOZILA Substudy
Yuqing Duan, Tadayoshi Hashimoto, Taro Shibuki, et al.
Nature Communications
|
July 13, 2024
Clinical features associated with NeoRAS wild-type metastatic colorectal cancer A SCRUM-Japan GOZILA substudy
Hiroki Osumi, Eiji Shinozaki, Yoshiaki Nakamura, et al.
ESMO Open
|
December 5, 2019
Rationale and design of the BRAVERY study (EPOC1701): a multicentre phase II study of eribulin in patients with <i>BRAF</i> V600E mutant metastatic colorectal cancer
Toshiki Masuishi, Hiroya Taniguchi, Daisuke Kotani, et al.
JCO Precision Oncology
|
January 17, 2025
Artificial Intelligence-Powered Human Epidermal Growth Factor Receptor 2 and Tumor Microenvironment Analysis in Human Epidermal Growth Factor Receptor 2-Amplified Metastatic Colorectal Cancer: Exploratory Analysis of Phase II TRIUMPH Trial
Mitsuho Imai, Yoshiaki Nakamura, Sangwon Shin, et al.
International Journal of Clinical Oncology
|
June 9, 2026
A multicenter survey on BRAF screening for the implementation of perioperative cancer genomic medicine for resectable colorectal oligometastases
Shin Kobayashi, Nobuhisa Matsuhashi, Yusuke Suwa, et al.
Cancer Medicine
|
August 29, 2023
Role of plasma angiogenesis factors in the efficacy of first-line chemotherapy combined with biologics in RAS wild-type metastatic colorectal cancer: Results from the GI-SCREEN CRC-Ukit study
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, et al.
Page
of 19